# Akari Therapeutics

**Canonical:** https://apis.io/providers/akari-therapeutics/  
**Website:** https://www.akaritx.com  
**APIs profiled:** 1

Akari Therapeutics is an innovative targeted oncology company developing next‑generation antibody‑drug conjugates (ADCs) and a novel discovery engine. The firm focuses on advancing ADC payloads with novel immuno‑oncology payloads, expanding its intellectual property portfolio, and presenting corporate information through its investor and corporate sites.

## Kin Score — 15.8 / 100 (emerging)

Scored 2026-10-31 under rubric 0.25.0.

| Facet | Score |
|---|---|
| Discoverability | 55.4 |
| Contract Quality | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 31.0 |
| Access Clarity | 21.1 |

Regulatory layer — **Health**: 10.9 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |
| Pagination Ratio | na |
| Operation Distinctiveness | na |

## APIs (1)

- **Akari Therapeutics API** — API reference not publicly documented; no machine‑readable contract discovered.

## Security (1)

- **Akari Therapeutics Domain Security** — DMARC

## Tags

Company, Oncology, ADC, Biotechnology, Therapeutics, Clinical-Development

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/akari-therapeutics/). Scores are computed from the provider's own public artifacts under a published rubric.